Biotechnology · Healthcare
Head of Investor Relations
Head of Investor Relations
Taysha Gene Therapies, Inc. (TSHA)Equibles does not estimate personal net worth.
Get an email with a short summary when Taysha Gene Therapies, Inc. publishes a filing, an earnings call transcript or a press release.
Get TSHA alertsStephanie Webster is recorded as Head of Investor Relations at Taysha Gene Therapies, Inc. (TSHA). Stephanie Webster has spoken on 1 earnings call across 1 company, most recently for Taysha Gene Therapies, Inc. on November 12, 2026. Taysha Gene Therapies, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Taysha Gene Therapies, Inc. includes Sean Nolan (CEO and Board Member), Kamran Alam (CFO), Laura Sepp-Lorenzino (Board Member) and 2 others.
“Good morning, and welcome to Tayshia's third quarter, 2026 Financial Results and Corporate Update Conference Call. Earlier today, Tayshia issued a press release announcing financial results for the quarter ended September 30, 2026.”
Biotechnology · Healthcare
Head of Investor Relations